Current good manufacturing practices-compliant manufacture and measurement of biotin-labeled red blood cells.

导出 OA

翻译打印收藏纠错

作者： Albert D,Donnenberg ^[1] ; Tamir,Kanias ^[2] ; Darrell J,Triulzi ^[3] ; Catherine J,Dennis ^[4] ; Linda R,Moore ^[4] ; E Michael,Meyer ^[5] ; Derek,Sinchar ^[6] ; Joseph E,Kiss ^[3] ; Daniel P,Normolle ^[5] ; Mark T,Gladwin ^[6]

作者单位： University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, Pennsylvania, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA; McGowan Institute of Regenerative Medicine, Pittsburgh, Pennsylvania, USA. Electronic address: donnenbergad@upmc.edu. ^[1] Vitalant Research Institute, Denver, Colorado, USA. ^[2] University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, Pennsylvania, USA; Vitalant, Pittsburgh, Pennsylvania, USA. ^[3] University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. ^[4] University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA. ^[5] University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, Pennsylvania, USA. ^[6]

关键词 N-hydroxysuccinimidobiotin current good manufacturing practices flow cytometry red blood cell survival